We analyzed the immunoglobulin (Ig) variable heavy (IGHV) 
Introduction
Several studies have demonstrated that leukemic B cells of patients with chronic lymphocytic leukemia (CLL) express a restricted immunoglobulin (Ig) heavy chain repertoire and that expression of Ig variable heavy chain (IGHV) genes in CLL is not random. [1] [2] [3] [4] [5] One particular IGHV gene, the 51p1 allele of IGHV1-69, generally is expressed with little or no somatic mutation in 10-20% of all cases of this disease. 6 Furthermore, CLL B cells that express 51p1 have a preferential use of certain diversity (IGHD) and junctional (IGHJ) gene segments with restricted reading frames (RF) that encode relatively long third complementarity determining regions (CDR3), which have conserved amino acid motifs that are not characteristic of the CDR3s of the Ig expressed by nonneoplastic tonsilar or blood B cells that use 51p1. 3, 7, 8 The CDR3 typically is the most variable region of the Ig heavy chain and generally is directly involved in binding to conventional antigens. As such, the expression of such conserved Ig with restricted CDR3 argues that the Ig repertoire expressed in this disease is highly selected, suggesting a potential role for antigen in the development and/or progression of CLL.
More recently we identified 15 unrelated CLL cases that expressed nearly identical Ig, with Ig heavy and light chain variable regions encoded by 51p1 and IGKV3-20 (A27), respectively. 9 The heavy and light chains of these 15 samples were virtually identical to SMI, a previously characterized CLL that expressed a polyreactive IgM/κ autoantibody with lowaffinity binding activity for a variety of self-antigens. 10 The CDR3 regions of both the heavy and light chains together comprise the Ig binding site for antigen. The prevalent use of the 51p1 allele of IGHV1-69 in CLL with little or no somatic mutation allowed us to examine the effect of different Ig heavy chain CDR3 (HCDR3) motifs on Ig light chain pairing in CLL cases that otherwise expressed nearly identical Ig heavy chain variable regions. For this, we examined the For personal use only. on August 31, 2017 . by guest www.bloodjournal.org From IGKV and IGLV gene usage and CDR3 structure of 258 CLL cases that expressed unmutated Ig heavy chains encoded by 51p1 that were identified in a large cohort of 1,846 non-selected CLL cases followed by the CLL Research Consortium (CRC).
Materials and Methods

Patient material
Blood was collected from consenting patients who satisfied the diagnostic and immunophenotypic criteria for B cell CLL 11 and who presented for evaluation at the referral centers of the CRC. Institutional review board approval from each participating institution and informed consent were obtained in all cases, in accordance with the Declaration of Helsinki.
Peripheral blood mononuclear cells were isolated by density gradient centrifugation using FicollHypaque 1077 (Sigma, St. Louis, MO), washed twice, and analyzed directly or suspended in fetal calf serum containing 10% dimethylsulfoxide (DMSO; Sigma) for storage in liquid nitrogen. All samples contained more than 90% CLL B cells as assessed by flow cytometric analyses, and the isotype of the expressed light chains was determined by flow cytometry, as described. 9 The heavy and light chain sequences of samples CLL69A1-A15 have been described previously, designated CLL-A through CLL-O, respectively.
9
IGHV, IGKV and IGLV Gene Analyses
Total cellular RNA was isolated from 5 x 10 6 CLL B cells using RNeasy reagents (Qiagen, Valencia, CA), per the manufacturer's instructions. First strand cDNA was synthesized from one-third of the total purified RNA using an oligo-dT primer and Superscript II RT (Invitrogen, Carlsbad CA). The remaining RNA was removed with RNaseH and the cDNA (Table S1 ). The PCR products were size selected by electrophoresis in 2% agarose containing 0.5 µg/ml of ethidium bromide (Invitrogen), and the expected products were excised and purified using
QIAquik purification columns (Qiagen). Most PCR products were sequenced directly, although in several cases the amplified products were cloned into pGEM-T (Promega, Madison, WI) and analyzed, as described. 14 Nucleic acid sequence analyses were conducted using the Fifteen functional IGLV genes were identified in the 76 IGLV-J rearrangements analyzed (Table 1) Table 2 ).
The restricted use of the genes in each group lead to conserved amino acid motifs that contained two amino acids (Pro-Asn) that were remarkably conserved considering they apparently were the result of N segment insertion. The Pro was likely due to the addition of cytidine by TdT, whereas the conserved Asn appeared to result from addition of two adenosine to the sequence encoded by IGHJ6. Seven of these ten samples had nearly identical LCDR3 of nine amino acid residues with the motif QVWDSSTEV. The other three had LCDR3 with either eight or ten amino acids residues that had virtually identical amino acid sequence motifs, as seven of the LCDR3 amino acid residues were encoded by IGLV3-9. Seven of the ten also had one amino acid at the IGLV-J junction that apparently was generated by N segment insertion to the final codon encoded by IGLJ. GGXYDYIWGSYRPNDAFDI. Fifteen of the samples included here were previously described. 9 Here we present 10 additional samples with HCDR3 that are nearly identical to the 
IGHD3-3 (CLL69C).
It should be noted that the Ig light chains encoded by any of the IGKV or IGLV genes identified in this study were not restricted to pairing with 51p1-encoded IgH with distinctive HCDR3. Indeed, light chains encoded by these genes also were found associated with disparate Ig heavy chains that lacked any of the four conserved HCDR3 motifs described in this study. In the case of the IGKV1-39 and 51p1-encoded IgH that used IGHD2-2, two samples did not have the characteristic Ig heavy chain CDR3 motif. However, one of the two samples did express a light chain encoded by IGKV1-39 that had the characteristic LCDR3 motif associated with subgroup CLL69B. Additionally, six other CLL samples that had HCDR3 that were encoded by IGHD genes other than IGHD2-2, and one that used IGHD2-2 with a different RF, 20 The restricted structures of the CLL B cell receptors that are expressed in this study strongly suggest selection for a characteristic binding activity. Several other groups have also recently reported subsets of CLL cases that express highly homologous or "stereotyped" CDR3 that express both mutated and unmutated Ig, 9,20,28-31 including a recent study by Stamatopoulos which estimates that over 20% of patients with CLL express "stereotyped" receptors. 31 As the probability of expressing such conserved Ig is less than 10 -12 , we and others have previously suggested that expression of Ig with restricted structures may influence the development of CLL. Recent immunophenotypic data suggested that CLL B cells that express mutated and unmutated Ig resemble activated and antigen-experienced B cells. [32] [33] [34] Although analysis of primary sequence data is unlikely to yield definitive clues regarding the nature of the potential antigen(s) involved in the development of CLL, some clues have been derived from comparison of the molecular characteristics of the Ig expressed by CLL B cells to antibodies with known reactivity, particularly those expressed in various autoimmune diseases.
CLL B cells frequently express IgM antibodies that display reactivity to self-antigens, [35] [36] [37] including several 51p1-encoded Ig that are polyreactive. 10, [38] [39] [40] [41] Several of the stereotyped Ig expressed by CLL B cells are highly similar in structure to antibodies with reactivity to selfantigens, including SMI, a previously characterized CLL that expressed a polyreactive IgM/κ autoantibody with low affinity for a number of self-antigens. 10 SMI is encoded by Ig heavy and light chains that are nearly identical to the 25 CLL Ig that belong to subgroup CLL69A.
Previous Ig structure function studies using recombinant Ig of SMI IgM/κ and other 51p1 and IGKV3-20-encoded heavy and light chains demonstrated that polyreactivity is not merely the result of the use of certain combinations of unmutated Ig heavy and light chains encoded by particular heavy and light chain genes, but rather is a selected specificity as the polyreactivity was dependent upon the CDR3 structure that was generated during Ig rearrangement. 10 Additionally, mutational analysis of specific amino acid residues demonstrated that certain CDR3 residues were critical for polyreactivity. 35, 42 In contrast, some antibodies are intrinsically autoreactive by virtue of their ability to bind to superantigens via framework region specific residues. 43 For example, the frequent expression of IgH encoded by IGHV4-34 led to speculation that superantigens may drive expansion of B cells that express Ig encoded by heavy chains were able to bind to NAL independent of the HCDR3 structure and light chain. 
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